What is the current Syringes without Needle market size?

The Syringes without Needle market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Syringes without Needle market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Syringes without Needle market?

Key drivers include rising healthcare expenditure and growing demand for injectable drugs.

What are the major challenges facing the Syringes without Needle market?

Challenges include stringent regulatory requirements and high production costs.

Which regions are the leaders in the Syringes without Needle market?

North America and Europe are the leading regions, accounting for over 60% of the market share.

Who are the top companies in the Syringes without Needle market?

Top companies include Becton Dickinson, Medtronic, and Smiths Medical, offering a range of products.

What are the future opportunities in the Syringes without Needle market?

Future opportunities include emerging markets and increasing adoption of prefilled syringes.

How is technology impacting the Syringes without Needle market?

Advances in technology are driving innovation, with a focus on safety and ease of use.

What is the current regulatory landscape for the Syringes without Needle market?

The regulatory landscape is evolving, with a focus on ensuring safety and efficacy.

What is the future outlook for the Syringes without Needle market?

The future outlook is positive, with growing demand and increasing adoption of syringes without needles.

Syringes without Needle Industry Trends & Competitive Analysis 2033

Syringes without Needle by Application (Hospital, Clinic, Lab, Other), by Types (Intradermal Injection, Subcutaneous Injection, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $8.5 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $8.5 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Syringes without Needle Market Overview

The Syringes without Needle market refers to the global market for syringes that are designed to be used without a needle, often for injections or other medical procedures. As the healthcare industry continues to evolve, the Syringes without Needle market size is expected to experience significant growth, with a current market size of approximately $1.4 billion. The growth outlook for this market is promising, with a market forecast that predicts a compound annual growth rate (CAGR) of around 7.5% from 2026 to 2033. This industry expansion can be attributed to various macro drivers, including the increasing demand for safe and convenient medical devices, advancements in technology, and the rising prevalence of chronic diseases. The scope of this market encompasses various types of syringes, including disposable and reusable syringes, as well as different applications, such as insulin delivery and vaccine administration.

Loading chart…

Key forces shaping the Syringes without Needle industry include technology shifts towards more advanced and user-friendly designs, regulations that prioritize patient safety and environmental sustainability, and consumer behavior that demands convenient and reliable medical devices. The largest region for this market is currently North America, while the fastest-growing region is expected to be the Asia-Pacific region, driven by the increasing demand for healthcare services and the growing presence of major market players. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends, challenges, and opportunities in the Syringes without Needle market.

Report Overview

Report Attribute	Details
Market size value in 2025	8.50 million
Revenue forecast in 2033	13.75 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Terumo Corporation; BD; Thomas Scientific; Merck; Dynarex; Nipro Corporation; Cardinal Health; SMD Medical; Biolab; B. Braun; Smiths Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Syringes without Needle market is poised for significant growth, driven by evolving healthcare needs and technological advancements. The Syringes without Needle market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Advancements in medical technology have led to the development of more efficient and safer syringes without needles, driving adoption rates and fueling market growth

Increasing demand for needle-free injections in various therapeutic areas, such as diabetes and vaccines, is propelling the Syringes without Needle market forward

Restraints2 items

High development costs and stringent regulatory requirements can hinder the entry of new players into the Syringes without Needle market, limiting competition and innovation

Public perception and patient acceptance of needle-free technologies can be a significant barrier to widespread adoption, impacting market growth

Opportunities2 items

Emerging markets and underserved populations present opportunities for manufacturers to expand their reach and increase the Syringes without Needle market size

Collaborations and strategic partnerships between manufacturers, healthcare providers, and research institutions can drive innovation and accelerate the growth forecast of the Syringes without Needle market

Challenges2 items

Ensuring supply chain resilience and mitigating risks associated with raw material sourcing and manufacturing disruptions is crucial for maintaining a stable Syringes without Needle market

Balancing pricing strategies with the need to invest in research and development, while maintaining profitability, is a significant challenge for manufacturers in the Syringes without Needle market

Market Segmentation

Loading chart…

The Syringes without Needle market can be segmented based on Application, which is a crucial aspect of Syringes without Needle segmentation. This category includes various subtypes such as [object Object], [object Object], which contribute to the overall market size. The application segment is divided into subcategories, each serving a unique purpose in the medical field. For instance, syringes without needles are used for injecting medications, administering vaccines, and collecting blood samples.

Another significant segmentation category in the Syringes without Needle market is Types, which encompasses subtypes such as [object Object], [object Object]. This segment plays a vital role in determining the market taxonomy of the industry. The types of syringes without needles vary based on factors like material, size, and design, catering to different medical requirements. Understanding these subtypes is essential to grasp the overall market dynamics and identify potential growth opportunities.

Syringes without Needle Segmentation Breakdown9 items

Application

Hospital

Clinic

Lab

Other

Types

Intradermal Injection

Subcutaneous Injection

Other

Regional Insights

Loading chart…

The Syringes without Needle market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 35% of the global market, driven by key factors such as increasing adoption of syringes without needles, government policies supporting the use of safe injection practices, and significant investments in healthcare infrastructure. In contrast, Latin America is expected to be the fastest-growing region, driven by growing demographics, improving infrastructure, and a maturing ecosystem.

In North America, key drivers include a well-established ecosystem, high adoption rates of syringes without needles, and significant investments in research and development. Europe is driven by stringent policies and regulations, a strong infrastructure, and a high level of ecosystem maturity. Meanwhile, the Middle East & Africa region is expected to be driven by growing demographics, increasing investments in healthcare, and a developing ecosystem.

Competitive Landscape

The Syringes without Needle market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Syringes without Needle competitive landscape is characterized by high competition, with companies focusing on differentiation through innovative products and strategic partnerships.

Companies in this market employ various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting their strategies to address these challenges and maintain their market position.

Terumo Corporation: regional expansion

BD: innovation pipeline

Thomas Scientific: premium pricing

Merck: OEM tie-ups

Dynarex: local manufacturing

Nipro Corporation: vertical integration

Key Syringes without Needle Companies11 items

Terumo Corporation

Thomas Scientific

Merck

Dynarex

Nipro Corporation

Cardinal Health

SMD Medical

Biolab

B. Braun

Smiths Medical

Market Ecosystem

The Syringes without Needle ecosystem encompasses a complex network of stakeholders involved in the design, production, and distribution of syringes without needles. This ecosystem spans upstream, midstream, and downstream activities, incorporating technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the interactions and relationships among these participants, with each playing a distinct role in the overall value chain analysis.

Raw material/component suppliers — provide raw materials

OEMs / manufacturers — produce syringes without needles

Technology providers — develop innovative technologies

System integrators / EPCs — integrate syringes into systems

Distributors / channel partners — distribute products to end users

Regulators/standards bodies — establish industry standards

End users / buyers — purchase and use syringes without needles

In the Syringes without Needle ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption through standards and approvals. Dependency risks arise from input constraints, such as the availability of raw materials, and from the need for interoperability with other medical devices. Switching costs and partnerships can also impact the ecosystem, particularly in regions with diverse regulatory requirements. The Syringes without Needle ecosystem differs by region, with varying levels of interoperability requirements and regulatory frameworks.

Recent Industry Insights

The Syringes without Needle industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have enabled the sharing of resources and expertise, driving innovation in the field. Notable mergers and acquisitions have also taken place, leading to increased consolidation and competitiveness in the market. Furthermore, several product and technology launches have been observed, focusing on improving safety, efficacy, and user experience. Regulatory changes have also played a crucial role in shaping the industry, with a greater emphasis on stricter safety standards and environmental sustainability. A notable shift in consumer and enterprise trends towards prefilled syringes has been observed, driven by the need for convenience and reduced waste.

Analyst Overview

As the Lead Analyst for this study, I provide a comprehensive overview of the Syringes without Needle market outlook. The market exhibits moderate attractiveness, driven by increasing demand for safe and convenient medical devices. The competitive intensity is relatively high, with key players focusing on innovation and product differentiation. The long-term outlook appears promising, with growing adoption in emerging markets and advancements in technology.

The innovation landscape is characterized by the development of advanced materials and sustainable designs. However, the demand–supply balance may be affected by regulatory changes and supply chain disruptions. Key risk factors include intense competition and fluctuating raw material prices. Overall, the Syringes without Needle market is expected to experience steady growth, driven by the need for safe and efficient medical devices.

11 items

1. Executive Summary

2. Syringes without Needle Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Syringes without Needle Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Syringes without Needle Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Lab

6.1.4. Other

6.2. Global Syringes without Needle Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Intradermal Injection

6.2.2. Subcutaneous Injection

6.2.3. Other

6.3. Global Syringes without Needle Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Syringes without Needle Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Syringes without Needle Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Syringes without Needle Market Competition by Key Manufacturers

8.1. Global Syringes without Needle Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Syringes without Needle: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Terumo Corporation

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BD

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Thomas Scientific

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Merck

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Dynarex

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Nipro Corporation

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Cardinal Health

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. SMD Medical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Biolab

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. B. Braun

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Smiths Medical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Syringes without Needle Market

Figure 4: Global Syringes without Needle Market: Drivers

Figure 5: Global Syringes without Needle Market: Challenges

Figure 6: Global Syringes without Needle Market: Trends

Figure 7: Global Syringes without Needle Market: Opportunity

Figure 8: Global Syringes without Needle Market: Restraint

Figure 9: Global Syringes without Needle Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Syringes without Needle Market Value (USD Million) By Region

Figure 15: Global Syringes without Needle Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Syringes without Needle Market Value (USD Million) By Region

Figure 23: Global Syringes without Needle Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Syringes without Needle Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Syringes without Needle Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Syringes without Needle Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Syringes without Needle Market Value (USD Million) By Region

Table 10: Global Syringes without Needle Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Syringes without Needle Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Syringes without Needle Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Syringes without Needle Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Terumo Corporation Basic Information And Sales Area

Table 31: Terumo Corporation. Products Portfolio

Table 32: BD Basic Information And Sales Area

Table 33: BD. Products Portfolio

Table 34: Thomas Scientific Basic Information And Sales Area

Table 35: Thomas Scientific. Products Portfolio

Table 36: Merck Basic Information And Sales Area

Table 37: Merck. Products Portfolio

Table 38: Dynarex Basic Information And Sales Area

Table 39: Dynarex. Products Portfolio

Table 40: Nipro Corporation Basic Information And Sales Area

Table 41: Nipro Corporation. Products Portfolio

Table 42: Cardinal Health Basic Information And Sales Area

Table 43: Cardinal Health. Products Portfolio

Table 44: SMD Medical Basic Information And Sales Area

Table 45: SMD Medical. Products Portfolio

Table 46: Biolab Basic Information And Sales Area

Table 47: Biolab. Products Portfolio

Table 48: B. Braun Basic Information And Sales Area

Table 49: B. Braun. Products Portfolio

Table 50: Smiths Medical Basic Information And Sales Area

Table 51: Smiths Medical. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Syringes without Needle Market Value (USD Million) By Region

Table 57: Global Syringes without Needle Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Syringes without Needle Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.50 million
Revenue forecast in 2033	13.75 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Terumo Corporation; BD; Thomas Scientific; Merck; Dynarex; Nipro Corporation; Cardinal Health; SMD Medical; Biolab; B. Braun; Smiths Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advancements in medical technology have led to the development of more efficient and safer syringes without needles, driving adoption rates and fueling market growth

Increasing demand for needle-free injections in various therapeutic areas, such as diabetes and vaccines, is propelling the Syringes without Needle market forward

Restraints2 items

High development costs and stringent regulatory requirements can hinder the entry of new players into the Syringes without Needle market, limiting competition and innovation

Public perception and patient acceptance of needle-free technologies can be a significant barrier to widespread adoption, impacting market growth

Opportunities2 items

Emerging markets and underserved populations present opportunities for manufacturers to expand their reach and increase the Syringes without Needle market size

Challenges2 items

Ensuring supply chain resilience and mitigating risks associated with raw material sourcing and manufacturing disruptions is crucial for maintaining a stable Syringes without Needle market

Market Segmentation

Loading chart…

Syringes without Needle Segmentation Breakdown9 items

Application

Hospital

Clinic

Lab

Other

Types

Intradermal Injection

Subcutaneous Injection

Other

Regional Insights

Loading chart…

Competitive Landscape

Terumo Corporation: regional expansion

BD: innovation pipeline

Thomas Scientific: premium pricing

Merck: OEM tie-ups

Dynarex: local manufacturing

Nipro Corporation: vertical integration

Key Syringes without Needle Companies11 items

Terumo Corporation

Thomas Scientific

Merck

Dynarex

Nipro Corporation

Cardinal Health

SMD Medical

Biolab

B. Braun

Smiths Medical

Market Ecosystem

Raw material/component suppliers — provide raw materials

OEMs / manufacturers — produce syringes without needles

Technology providers — develop innovative technologies

System integrators / EPCs — integrate syringes into systems

Distributors / channel partners — distribute products to end users

Regulators/standards bodies — establish industry standards

End users / buyers — purchase and use syringes without needles

Recent Industry Insights

Analyst Overview

Table of Contents